Wyeth, Amgen Face Patent Suit Over Enbrel
A British charitable trust has slapped Amgen Inc. and Pfizer Inc. subsidiary Wyeth with a lawsuit over the lucrative rheumatoid arthritis drug Enbrel, accusing the two defendants — which co-market Enbrel...To view the full article, register now.
Already a subscriber? Click here to view full article